FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072613621> ?p ?o ?g. }

• W2072613621 endingPage "629" @default.
• W2072613621 startingPage "627" @default.
• W2072613621 abstract "To the Editor: Asthma heterogeneity has been described by the nature and intensity of granulocytic infiltration into the airways [1, 2]. Sputum, endobronchial biopsies and bronchoalveolar lavage (BAL) sample different anatomical regions of the airways. Few studies have directly compared the inflammatory cell infiltrates in these regions within a large cohort of moderate–severe asthma patients using standard techniques.In the BOBCAT (Bronchoscopic exploratory research study Of Biomarkers in Corticosteroid-refractory AsThma) study, we sampled multiple airway compartments concurrently, enabling us to evaluate relationships between granulocytic infiltrates within and between compartments in a large cohort of moderate–severe adult asthma patients. This prospective multicentre observational study was conducted in four visits over a 4–6 week period, as described previously [3].The patients included had moderate–severe persistent asthma (forced expiratory volume in 1 s (FEV1) 40–80% predicted and Asthma Control Questionnaire (ACQ) [4] score >1.5) and, within the past 5 years, evidence of >12% post-bronchodilator reversibility or a provocative concentration of methacholine causing a 20% decline in FEV1 ≤8 mg·mL−1 despite high-dose inhaled corticosteroid (ICS) (≥1000 μg·day−1 fluticasone propionate equivalent) with or without long-acting β2-adrenergic agonist therapy. Key exclusion criteria included initiation or increase in systemic steroid use 30 days prior to screening, chronic or recent (within the past 30 days) use of immunosuppressive therapies, or other active lung disease. Patients had a prior established diagnosis of moderate–severe asthma for ≥6 months prior to screening while receiving a stable dose regimen (>6 weeks) of a high-dose ICS. Allowed concomitant medications included leukotriene receptor antagonists and oral corticosteroids.78 patients with confirmed moderate–severe asthma were enrolled at 18 sites; 67 (86%) completed the study. All patients had persistently impaired …" @default.
• W2072613621 created "2016-06-24" @default.
• W2072613621 creator A5004680358 @default.
• W2072613621 creator A5005205857 @default.
• W2072613621 creator A5006440043 @default.
• W2072613621 creator A5011606845 @default.
• W2072613621 creator A5016521386 @default.
• W2072613621 creator A5018374796 @default.
• W2072613621 creator A5027127170 @default.
• W2072613621 creator A5029497606 @default.
• W2072613621 creator A5029849168 @default.
• W2072613621 creator A5036199727 @default.
• W2072613621 creator A5046390561 @default.
• W2072613621 creator A5046872821 @default.
• W2072613621 creator A5048656238 @default.
• W2072613621 creator A5048807148 @default.
• W2072613621 creator A5050706034 @default.
• W2072613621 creator A5073165570 @default.
• W2072613621 creator A5074783469 @default.
• W2072613621 creator A5084946954 @default.
• W2072613621 creator A5090022167 @default.
• W2072613621 creator A5091297501 @default.
• W2072613621 date "2013-10-31" @default.
• W2072613621 modified "2023-10-15" @default.
• W2072613621 title "Disconnect between sputum neutrophils and other measures of airway inflammation in asthma" @default.
• W2072613621 cites W1988758075 @default.
• W2072613621 cites W1993997407 @default.
• W2072613621 cites W2033712059 @default.
• W2072613621 cites W2051954214 @default.
• W2072613621 cites W2053208368 @default.
• W2072613621 cites W2063801679 @default.
• W2072613621 cites W2108919922 @default.
• W2072613621 cites W2109781176 @default.
• W2072613621 cites W2111609315 @default.
• W2072613621 cites W2162645440 @default.
• W2072613621 doi "https://doi.org/10.1183/09031936.00117013" @default.
• W2072613621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24176993" @default.
• W2072613621 hasPublicationYear "2013" @default.
• W2072613621 type Work @default.
• W2072613621 sameAs 2072613621 @default.
• W2072613621 citedByCount "29" @default.
• W2072613621 countsByYear W20726136212014 @default.
• W2072613621 countsByYear W20726136212015 @default.
• W2072613621 countsByYear W20726136212016 @default.
• W2072613621 countsByYear W20726136212017 @default.
• W2072613621 countsByYear W20726136212018 @default.
• W2072613621 countsByYear W20726136212019 @default.
• W2072613621 countsByYear W20726136212020 @default.
• W2072613621 countsByYear W20726136212021 @default.
• W2072613621 countsByYear W20726136212022 @default.
• W2072613621 countsByYear W20726136212023 @default.
• W2072613621 crossrefType "journal-article" @default.
• W2072613621 hasAuthorship W2072613621A5004680358 @default.
• W2072613621 hasAuthorship W2072613621A5005205857 @default.
• W2072613621 hasAuthorship W2072613621A5006440043 @default.
• W2072613621 hasAuthorship W2072613621A5011606845 @default.
• W2072613621 hasAuthorship W2072613621A5016521386 @default.
• W2072613621 hasAuthorship W2072613621A5018374796 @default.
• W2072613621 hasAuthorship W2072613621A5027127170 @default.
• W2072613621 hasAuthorship W2072613621A5029497606 @default.
• W2072613621 hasAuthorship W2072613621A5029849168 @default.
• W2072613621 hasAuthorship W2072613621A5036199727 @default.
• W2072613621 hasAuthorship W2072613621A5046390561 @default.
• W2072613621 hasAuthorship W2072613621A5046872821 @default.
• W2072613621 hasAuthorship W2072613621A5048656238 @default.
• W2072613621 hasAuthorship W2072613621A5048807148 @default.
• W2072613621 hasAuthorship W2072613621A5050706034 @default.
• W2072613621 hasAuthorship W2072613621A5073165570 @default.
• W2072613621 hasAuthorship W2072613621A5074783469 @default.
• W2072613621 hasAuthorship W2072613621A5084946954 @default.
• W2072613621 hasAuthorship W2072613621A5090022167 @default.
• W2072613621 hasAuthorship W2072613621A5091297501 @default.
• W2072613621 hasBestOaLocation W20726136211 @default.
• W2072613621 hasConcept C105922876 @default.
• W2072613621 hasConcept C142724271 @default.
• W2072613621 hasConcept C203014093 @default.
• W2072613621 hasConcept C2776042228 @default.
• W2072613621 hasConcept C2776301714 @default.
• W2072613621 hasConcept C2776914184 @default.
• W2072613621 hasConcept C2781069245 @default.
• W2072613621 hasConcept C42219234 @default.
• W2072613621 hasConcept C71924100 @default.
• W2072613621 hasConceptScore W2072613621C105922876 @default.
• W2072613621 hasConceptScore W2072613621C142724271 @default.
• W2072613621 hasConceptScore W2072613621C203014093 @default.
• W2072613621 hasConceptScore W2072613621C2776042228 @default.
• W2072613621 hasConceptScore W2072613621C2776301714 @default.
• W2072613621 hasConceptScore W2072613621C2776914184 @default.
• W2072613621 hasConceptScore W2072613621C2781069245 @default.
• W2072613621 hasConceptScore W2072613621C42219234 @default.
• W2072613621 hasConceptScore W2072613621C71924100 @default.
• W2072613621 hasIssue "2" @default.
• W2072613621 hasLocation W20726136211 @default.
• W2072613621 hasLocation W20726136212 @default.
• W2072613621 hasOpenAccess W2072613621 @default.
• W2072613621 hasPrimaryLocation W20726136211 @default.
• W2072613621 hasRelatedWork W1980252166 @default.
• W2072613621 hasRelatedWork W2337979172 @default.

• next